Cognitive behaviour therapy for excessive worry over health in medical patients
| ISRCTN | ISRCTN14565822 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN14565822 |
| Secondary identifying numbers | HTA 07/01/26 |
- Submission date
- 17/06/2008
- Registration date
- 20/06/2008
- Last edited
- 17/05/2016
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Mental and Behavioural Disorders
Plain English Summary
Background and study aims
Hypochondriasis, or health anxiety, is a significant problem in all parts of clinical practice, but has been largely ignored by services until recently. Our studies, and those of others, suggest that between 1 in 4 and 1 in 10 of all those attending medical clinics have significant health anxiety and this accounts for both considerable suffering and unnecessary use of resources. One of the characteristics of those with severe health anxiety is that it persists and leads to frequent medical consultations in both primary and secondary care. This represents a significant drain on health service resources at a time of considerable cost pressures, and, in addition, the symptoms of health anxiety are highly troubling and disturbing, are associated with much time off work, and adversely affect social functioning. In a study of treatment in a genitourinary medicine clinic, we found that a short course of cognitive behaviour therapy (CBT) was highly effective at reducing health anxiety, and that these benefits are maintained over a period of one year. We also found that the number of consultations in both general practice and the clinics fell in those in the active treatment group over one year but the savings made were small as the costs of investigations are relatively low. We are now planning a larger study of CBT to treat health anxiety in cardiology, respiratory medicine, gastroenterology and endocrinology clinics, where such anxiety is more common than in genuitourinary medicine.
Who can participate?
Patients aged between 16 and 75 attending four medical specialty clinics (in cardiology, respiratory medicine, gastroenterology and endocrinology) who have significant health anxiety
What does the study involve?
Participants are randomly allocated to one of two groups. One group is treated with CBT adapted for health anxiety in the form of between 5 and 10 one-hour sessions, which will address abnormal worries about health and ways of overcoming them. The other group is treated with a single 45-minute explanatory interview describing the nature of health anxiety and how it tends to be perpetuated. We measure patients’ functioning, anxiety and quality of life, as well as health service and employment costs, at the start of the study and at 6 monthly intervals for two years, to see whether the costs of treatment are offset by savings on attendance and investigations over 2 years.
What are the possible benefits and risks of participating?
Not provided at time of registration
Where is the study run from?
Imperial College London (UK)
When is the study starting and how long is it expected to run for?
October 2008 to September 2012
Who is funding the study?
Health Technology Assessment Programme (UK)
Who is the main contact?
Prof. Peter Tyrer
p.tyrer@imperial.ac.uk
Contact information
Scientific
Department of Psychological Medicine
St Dunstan's Road
London
W6 8RP
United Kingdom
| Phone | +44 (0)207 386 1237 |
|---|---|
| p.tyrer@imperial.ac.uk |
Study information
| Study design | Randomised controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Not specified |
| Study type | Treatment |
| Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
| Scientific title | Cognitive behaviour therapy for Health Anxiety in Medical Patients |
| Study acronym | CHAMP |
| Study hypothesis | Cognitive behaviour therapy adapted for health anxiety is a cost-effective way of treating patients with significant health anxiety in medical clinics. More details can be found at: http://www.nets.nihr.ac.uk/projects/hta/070126 Protocol can be found at: http://www.nets.nihr.ac.uk/__data/assets/pdf_file/0017/51731/PRO-07-01-26.pdf |
| Ethics approval(s) | Nottingham Research Ethics Committee 1, 13/06/2008, ref: 08/H0403/56 |
| Condition | Hypochondriasis/mental health |
| Intervention | Arm 1: Cognitive behaviour therapy adapted for health anxiety (Warwick/Salkovskis model). Treatment will be given for between 5 and 10 one hour sessions for each patient, and will address abnormal worries about health and ways of overcoming them. Arm 2: Single explanatory interview of the nature of health anxiety. This will be a single interview of 45 minutes describing the nature of health anxiety and how it tends to be perpetuated. Duration of interventions: up to 6 months Duration of follow-up: 2 years |
| Intervention type | Other |
| Primary outcome measure | Reduction in health anxiety scores 1 year after randomisation. |
| Secondary outcome measures | 1. Reduction in health anxiety scores 2 years after randomisation 2. Presence or absence of diagnosis of hypochondriasis at 1 and 2 years after randomisation 3. Reduction in generalised anxiety and depression, assessed using the Hospital Anxiety and Depression Scale (HADS) at 1 and 2 years after randomisation 4. Improvement in social function and quality of life, assessed using the Social Functioning Questionnaire (SFQ) and Euroqol EQ-5D at 1 and 2 years after randomisation 5. Total costs of health care (primary and secondary) 1 and 2 years after randomisation 6. Change in presenteeism and absenteeism at work 1 and 2 years after randomisation |
| Overall study start date | 01/10/2008 |
| Overall study end date | 30/09/2012 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | Both |
| Target number of participants | 465 |
| Participant inclusion criteria | Patients attending four medical specialty clinics (in cardiology, respiratory medicine, gastroenterology and endocrinology) who: 1. Have significant health anxiety (score of 20 or more on the Health Anxiety Inventory) 2. Are aged between 16 and 75 (both males and females) 3. Are living independently 4. Are permanent residents in the area 5. Have sufficient understanding of English to read and complete the questionnaires 6. Give written consent for the interviews, including audiotaping of half the sessions 7. Give written consent for access to their medical records |
| Participant exclusion criteria | Patients who are: 1. Considered too ill in medical terms by their consultants to be considered for the study 2. In the process of being investigated for significant pathology and for whom cognitive behaviour therapy might confuse or cause distress 3. Those who have significant cognitive impairment |
| Recruitment start date | 01/10/2008 |
| Recruitment end date | 30/09/2012 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
W6 8RP
United Kingdom
Sponsor information
University/education
Charing Cross Campus
St Dunstan's Road
London
W6 8RP
England
United Kingdom
| Phone | +44 (0)207 386 1233 |
|---|---|
| gary.roper@imperial.ac.uk | |
| Website | http://www3.imperial.ac.uk |
"ROR" |
https://ror.org/041kmwe10 |
Funders
Funder type
Government
Government organisation / National government
- Alternative name(s)
- NIHR Health Technology Assessment Programme, HTA
- Location
- United Kingdom
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Protocol article | protocol | 14/06/2011 | Yes | No | |
| Results article | results | 18/01/2014 | Yes | No |
Editorial Notes
17/05/2016: Plain English summary added.
